Hrain Biotechnology has pocketed 200 million yuan ($29 million) in a Series B+ round, while Weier Technology has raised “tens of millions of US dollars” in a Series B round led by Qiming Venture Partners.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in